DOD Biotech PCL (BKK:DOD) Beta: 1.5566 (As of Jun. 27, 2026)


BKK:DOD DOD Biotech PCL BKK:DOD
76 GF Score
Price ฿1.50
GF Value ฿1.67
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DOD Biotech PCL Beta?

DOD Biotech PCL BKK:DOD 76 Beta is 1.5566 as of Jun. 27, 2026. GuruFocus rates BKK:DOD with a GF Score™ of 76/100 and a GF Value™ of ฿1.67 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-27), DOD Biotech PCL's Beta is 1.5566.


DOD Biotech PCL  (BKK:DOD) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


DOD Biotech PCL Beta Related Terms


DOD Biotech PCL Beta Historical Data

* Premium members only.

The historical data trend for DOD Biotech PCL's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DOD Biotech PCL Beta Chart

DOD Biotech PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 1.68 0.95 2.30 1.61

DOD Biotech PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.10 1.48 1.67 1.61 1.63

BKK:DOD vs KHC, GIS: Beta Comparison

For the Packaged Foods subindustry, DOD Biotech PCL's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DOD Biotech PCL Beta vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Beta distribution charts can be found below:

* The bar in red indicates where DOD Biotech PCL's Beta falls into.


BKK:DOD
76GF Score
DOD Biotech PCL BKK:DOD
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DOD Biotech PCL Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.5566 mean?
DOD Biotech PCL (BKK:DOD) has a Beta of 1.5566 as of Jun. 27, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for DOD Biotech PCL and its competitors.
Is DOD Biotech PCL's Beta too high?
DOD Biotech PCL's current Beta is 1.5566. Overall, DOD Biotech PCL has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Beta compare to KHC and GIS?
DOD Biotech PCL's Beta of 1.5566 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Consumer Packaged Goods company?
A good Beta depends on the Consumer Packaged Goods industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for DOD Biotech PCL and its competitors. DOD Biotech PCL's current Beta is 1.5566. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.50 — trading 10.2% below its estimated fair value. The current Beta is 1.5566. DOD Biotech PCL's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current Beta is 1.5566 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?

Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued. The current stock price of ฿1.50 is trading 10.2% below its estimated GF Value™ of ฿1.67. GuruFocus considers DOD Biotech PCL to be Modestly Undervalued.

Key valuation signals for BKK:DOD:

  • Beta: 1.5566
  • GF Value™: ฿1.67 vs. price of ฿1.50 (10.2% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DOD Biotech PCL Business Description

Address No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
76GF Score

Get the complete analysis for BKK:DOD

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.50
Price
฿1.67
GF Value